← Back to Search

Behavioral Intervention

2 for Anxiety Disorders (MADONA Trial)

N/A
Waitlist Available
Led By André Marchand, PhD
Research Sponsored by Université du Québec a Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

The purpose of this study is to assess the impact of three different treatment modalities on panic symptoms, quality of life and use of health services among individuals consulting an emergency department for non cardiac chest pain and having Panic Disorder.

Eligible Conditions
  • Anxiety Disorders
  • Panic Disorder
  • Psychiatric Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

4Treatment groups
Active Control
Group I: 2Active Control1 Intervention
Group II: 3Active Control1 Intervention
Group III: 4Active Control1 Intervention
Group IV: 1Active Control1 Intervention

Find a Location

Who is running the clinical trial?

Université du Québec a MontréalLead Sponsor
24 Previous Clinical Trials
5,189 Total Patients Enrolled
1 Trials studying Anxiety Disorders
80 Patients Enrolled for Anxiety Disorders
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,373 Previous Clinical Trials
26,519,038 Total Patients Enrolled
20 Trials studying Anxiety Disorders
7,495 Patients Enrolled for Anxiety Disorders
André Marchand, PhDPrincipal InvestigatorUniversité du Québec a Montréal
~10 spots leftby Sep 2025